Selectis Health (GBCS) Liabilities and Shareholders Equity (2011 - 2025)

Selectis Health's Liabilities and Shareholders Equity history runs 15 years deep, the most recent figure standing at $32.6 million for Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity fell 2.6% year-over-year to $32.6 million; the TTM figure through Dec 2025 stood at $134.0 million (down 6.71% YoY), while the FY2025 annual figure was $32.6 million, down 2.6% from the prior year.
• Liabilities and Shareholders Equity came in at $32.6 million for Q4 2025 at Selectis Health, down from $33.3 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $48.7 million in Q1 2023 to a low of $32.6 million in Q4 2025.
• A 5-year average of $41.1 million and a median of $42.4 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity gained 11.73% in 2021 and slipped 21.75% in 2024, its largest moves.
• Selectis Health's Liabilities and Shareholders Equity stood at $46.9 million in 2021, then declined by 9.45% to $42.5 million in 2022, then retreated by 4.28% to $40.7 million in 2023, then declined by 17.76% to $33.4 million in 2024, then decreased by 2.6% to $32.6 million in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $32.6 million, $33.3 million, and $33.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison